A. Sinclair Dunlop

Companies

• Apellis Pharmaceuticals, Inc.Board member Nov 8, 2017 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• APApellis Pharmaceuticals, Inc.0 shares²May 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 14, 2026Returned to company 3,544 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 7,961 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 5,744 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 3,062 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026U 161,567 shares of Apellis Pharmaceuticals, Inc.²
• Jan 1, 2026Granted 7,961 shares of Apellis Pharmaceuticals, Inc.³
• Oct 10, 2025Other 3,837 shares of Apellis Pharmaceuticals, Inc.⁴
• Oct 10, 2025Sold 31,092 shares at $23.72 of Apellis Pharmaceuticals, Inc.⁴
• Sep 30, 2025Other 3,837 shares of Apellis Pharmaceuticals, Inc.⁵
• Sep 30, 2025Sold 31,092 shares at $22.58 of Apellis Pharmaceuticals, Inc.⁵
• Sep 19, 2025Other 3,837 shares of Apellis Pharmaceuticals, Inc.⁶
• Sep 19, 2025Sold 31,092 shares at $22.95 of Apellis Pharmaceuticals, Inc.⁶
• Jun 24, 2025Other 4,787 shares of Apellis Pharmaceuticals, Inc.⁴
• Jan 1, 2025Granted 6,267 shares of Apellis Pharmaceuticals, Inc.⁷
• Sep 23, 2024Exercised options 4,600 shares at $13.19 of Apellis Pharmaceuticals, Inc.⁸
• Sep 16, 2024Sold 7,524 shares at $36.79 of Apellis Pharmaceuticals, Inc.⁹
• Sep 16, 2024Sold 29,476 shares at $36.09 of Apellis Pharmaceuticals, Inc.⁹
• Jun 28, 2024Exercised options 900 shares at $13.19 of Apellis Pharmaceuticals, Inc.¹⁰
• Jun 21, 2024Sold 1,695 shares at $39.63 of Apellis Pharmaceuticals, Inc.¹¹
• Jun 21, 2024Sold 35,305 shares at $39.22 of Apellis Pharmaceuticals, Inc.¹¹
• Apr 12, 2024Exercised options 1,500 shares at $13.19 of Apellis Pharmaceuticals, Inc.¹²
• Mar 19, 2024Sold 18,681 shares at $57.18 of Apellis Pharmaceuticals, Inc.¹³
• Jan 1, 2024Granted 3,341 shares of Apellis Pharmaceuticals, Inc.¹⁴
• Dec 14, 2023Exercised options 6,274 shares at $13.19 of Apellis Pharmaceuticals, Inc.¹⁵
• Dec 1, 2023Sold 24,000 shares at $61.14 of Apellis Pharmaceuticals, Inc.¹⁶